These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 158753)

  • 1. Correlation of mixed lymphocyte culture reactivity and graft survival in one haplotype-matched recipients.
    Garovoy MR; Person A; Carpenter CB
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():208-11. PubMed ID: 158753
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor-specific blood transfusions in HLA-D-disparate one-haplotype-related allografts.
    Cochrum KC; Hanes D; Potter D; Vincenti F; Amend W; Feduska N; Perkins H; Salvatierra O
    Transplant Proc; 1979 Dec; 11(4):1903-7. PubMed ID: 161102
    [No Abstract]   [Full Text] [Related]  

  • 3. [HLA-compatibility testing in kidney transplantation--past, present and future].
    van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Lansbergen Q; Cohen B
    Chirurg; 1980 May; 51(5):257-62. PubMed ID: 6447582
    [No Abstract]   [Full Text] [Related]  

  • 4. MLC, PHA, HLA, and DRw studies in renal allografting.
    Braun WE; Jayavant M; Dejelo C; Zachary A; Novick A; Santos N; Williams T
    Transplant Proc; 1979 Dec; 11(4):1911-3. PubMed ID: 161103
    [No Abstract]   [Full Text] [Related]  

  • 5. The correlation of tissue typing, mixed lymphocyte culture, and related donor renal allograft survival.
    Cerilli J; Newhouse YG; Williams MA
    Transplant Proc; 1978 Dec; 10(4):953-4. PubMed ID: 153622
    [No Abstract]   [Full Text] [Related]  

  • 6. MLC compatibility, HLA-D and DR typing in cadaver kidney transplantations.
    Thomsen M; Morling N; Ladefoged J; Løkkegård H; Jakobsen B; Svejgaard A; Thaysen JH
    Scand J Urol Nephrol Suppl; 1980; 54():32-5. PubMed ID: 6452681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for inbreeding, MHC haplotype matching, and prolonged kidney graft survival in Yucatan miniature swine.
    Eiras-Hreha G; Hough K; Cramer DV; Hill D; Cosenza C; Ulker N; Chapman F; Makowka L
    Transplantation; 1993 Jan; 55(1):224-7. PubMed ID: 8093566
    [No Abstract]   [Full Text] [Related]  

  • 8. Pretransplant blood transfusions and kidney allograft survival. A clinical and immunological study.
    Fehrman I
    Scand J Urol Nephrol Suppl; 1981; 65():1-46. PubMed ID: 6217543
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of HLA-DR matching between living kidney donors and recipients and of pretransplant blood transfusions on graft survival.
    Akiyama N; Sugimoto H; Kusaba R; Takahashi I; Ohsawa N; Inou T; Samaru Y
    Jpn J Exp Med; 1981 Feb; 51(1):37-43. PubMed ID: 6458714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of mixed leukocyte culture reactivity by sera from hemodialysis patients and transplant recipients as an indicator of isoimmunization.
    Suciu-Foca N; Buda JA; Thiem T; Almojera P; Reemtsma KB
    Lab Invest; 1974 Jul; 31(1):1-5. PubMed ID: 4276465
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship of mixed lymphocyte culture (MLC) response and kidney graft survival in living related donor transplants.
    Lazda VA; Jonasson O; Mozes MF
    Transplant Proc; 1981 Mar; 13(1 Pt 2):949-52. PubMed ID: 6455829
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of clinical response of DR-matched, MLC-compatible cadaver renal allografts and those from HLA-identical related donors.
    Conti DJ; Andersen R; Soper WD; Wolf JS
    Transplant Proc; 1987 Feb; 19(1 Pt 1):652-4. PubMed ID: 2978928
    [No Abstract]   [Full Text] [Related]  

  • 13. The correlation of MLC with graft survival.
    Cochrum KC; Perkins HA; Payne RO; Kountz SL; Belzer FO
    Transplant Proc; 1973 Mar; 5(1):391-6. PubMed ID: 4266666
    [No Abstract]   [Full Text] [Related]  

  • 14. Prediction of kidney transplant survival by the direct macrophage-inhibition test.
    Schweizer RT; Olson EC; Hosey DA; Bartus SA
    Transplant Proc; 1979 Mar; 11(1):411-4. PubMed ID: 156427
    [No Abstract]   [Full Text] [Related]  

  • 15. MLC incompatibility index for donor--recipient matching.
    Uehling DT; Hussey JL; Belzer FO; Kan C; Bach FH
    Transplant Proc; 1977 Mar; 9(1):103-5. PubMed ID: 141120
    [No Abstract]   [Full Text] [Related]  

  • 16. Graft survival in unrelated donor--recipient pairs matched for MLC and HL-A.
    van Rood JJ; Koch CT; van Hooff JP; van Leeuwen A; van den Tweel JG; Frederiks E; Schippers HM; Hendriks G; van der Steen GJ
    Transplant Proc; 1973 Mar; 5(1):409-14. PubMed ID: 4266668
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of T-cell-mediated cytotoxic allograft response in human transplant recipients.
    Thomas J; Thomas F; Edwards E; Hoffman S; Lee HM
    Transplant Proc; 1981 Sep; 13(3):1594-8. PubMed ID: 6458130
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic preparation for cadaver renal transplant by thoracic duct drainage.
    Johnson HK; Niblack GD; Tallent MB; Richie RE
    Transplant Proc; 1977 Sep; 9(3):1499-1503. PubMed ID: 143094
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of low donor-specific MLR versus HLA-DR compatibility on kidney graft survival.
    Langhoff E; Jakobsen BK; Platz P; Ryder LP; Svejgaard A
    Transplantation; 1985 Jan; 39(1):18-21. PubMed ID: 2578235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of mixed lymphocyte culture (MLC) in renal transplants from living donors].
    Zanuso C; Pontiero P; Ancona G; Galvani E; Confortini P
    Minerva Chir; 1980 May; 35(10):791-2. PubMed ID: 6450337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.